Wednesday, July 16, 2025 8:24:10 AM
The presence of increasing number of minions that post such BS including some medical doctors on a non stop basis only means that UK approval is far away and LP has nothing meaningful up her sleeve post approval.
The theory of DennisDave that there will be a partnership or buyout from big pharma soon after UK approval because LP hasn’t prepared for commercialization will also be proven wrong. Why would they have such minions post crap non stop and damage their credibility if a deal was pretty much inked contingent on UK approval? There is just no need as the deal will take care of everything including the agreed upon market cap or upfront cash for partnership depending on the deal structure, which in turn will take care of the share price. Poor dennisdave, he has a history of being toyed by his friends!
Folks will learn the hard way when LP comes empty handed and more excuses, dilution in pennies, and increase in authorized share count follow post UK approval! It may be a bit too late for some folks to take money off the table as the shares would have given up UK approval spike gains by then. The carrot dangling around Flaskworks and new clinical trials will then get even louder to keep shareholders on the hook while the share price eventually touches new all time lows.
The theory of DennisDave that there will be a partnership or buyout from big pharma soon after UK approval because LP hasn’t prepared for commercialization will also be proven wrong. Why would they have such minions post crap non stop and damage their credibility if a deal was pretty much inked contingent on UK approval? There is just no need as the deal will take care of everything including the agreed upon market cap or upfront cash for partnership depending on the deal structure, which in turn will take care of the share price. Poor dennisdave, he has a history of being toyed by his friends!
Folks will learn the hard way when LP comes empty handed and more excuses, dilution in pennies, and increase in authorized share count follow post UK approval! It may be a bit too late for some folks to take money off the table as the shares would have given up UK approval spike gains by then. The carrot dangling around Flaskworks and new clinical trials will then get even louder to keep shareholders on the hook while the share price eventually touches new all time lows.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
